Men are remarkably good at tolerating discomfort and remarkably bad at reporting it. Ask a urologist what the most common delay in genitourinary cancer care looks like, and the answer is rarely a diagnostic failure. It is a man who noticed something odd eight months ago, decided it would settle, and said nothing until a partner or a routine insurance physical forced the issue. Testicular cancer tends to arrive in men between roughly 15 and 45 — the decades when most men have no regular doctor at all. Prostate cancer arrives later, usually without symptoms, which is why conversations about screening matter more than waiting for a sign.
This is not a lecture about willpower. It is a practical guide to what is worth examining, what a PSA number does and does not tell you, and what modern treatment options look like now that single, one-size-fits-all approaches have largely given way to risk-tailored care.
The stoicism problem
Cultures that reward endurance tend to produce men who under-report symptoms. The military is the clearest example: the same mindset that lets someone keep moving under fire is the mindset that dismisses a painless lump as unimportant. Coverage of decorated service members — such as the account of a US Army colonel receiving the Distinguished Service Cross — captures the discipline that makes those careers possible, and it is worth saying plainly that the same discipline, applied to a five-minute self-check once a month, is not weakness. First responders, construction workers, long-haul drivers and shift workers show the same pattern. The behaviour is cultural, not biological, which means it is changeable.
Testicular self-examination: what you are feeling for
A self-exam takes about two minutes and is easiest after a warm shower, when the scrotal skin is relaxed. Hold one testicle at a time between thumb and fingers and roll it gently, feeling the whole surface. You are building a mental baseline so you can notice a change later.
-
A firm, usually painless lump or nodule on the surface of the testicle
-
A change in size, shape or firmness, or one testicle becoming noticeably heavier
-
A dull ache in the lower abdomen or groin, or a dragging, heavy sensation in the scrotum
-
Sudden fluid collection in the scrotum, or enlargement or tenderness of breast tissue
-
Back pain or unexplained shortness of breath that does not resolve
Two anatomical notes prevent most false alarms. The epididymis — a soft, coiled structure at the back and top of the testicle — is normal and often mistaken for a mass. Veins in the scrotum can feel like a small bag of worms; that is usually a varicocele, not cancer. The reverse mistake is more dangerous: assuming that because a lump does not hurt, it can be ignored. Most testicular tumors are painless.
Known risk factors include a history of undescended testicle, a family history of the disease, previous testicular cancer in the other testicle, and certain developmental conditions. These raise risk; they do not determine outcome, and nothing you can do to your diet or training schedule removes them. The practical response is awareness, not anxiety. Assessment usually begins with an examination, a scrotal ultrasound and blood tests for tumor markers, followed by imaging to see whether disease has spread.
PSA testing: a useful signal, not a verdict
Prostate-specific antigen is a protein made by prostate tissue. A raised PSA means the prostate is producing more of it than expected — which can reflect cancer, but also benign enlargement, inflammation, a recent urinary infection, a long bike ride or recent ejaculation. That is why no competent clinician treats a single number as a diagnosis.
What a sensible conversation sounds like
Most guidelines frame screening as a shared decision, typically starting in a man’s fifties, or earlier — often from around age 40 to 45 — for men with a family history of prostate cancer or of African ancestry. The discussion should cover the trade-off honestly: screening can find aggressive disease early, and it can also find slow-growing cancer that would never have caused harm, leading to investigations and treatment some men would rather have avoided. Trend matters more than a single reading. A PSA that climbs steadily over two years is more interesting than one that sits slightly above a textbook threshold and stays there.
Modern pathways have reduced unnecessary intervention considerably. Multiparametric MRI before biopsy helps identify which men need tissue sampling and where to target it. Active surveillance — monitoring low-risk disease with repeat PSA, imaging and biopsies rather than treating immediately — is now standard practice for a substantial group of men, not a compromise.
Where treatment has moved
For localized prostate cancer, the menu is wider than surgery versus conventional radiation. High-intensity focused ultrasound treats a targeted region of the gland using focused sound energy, an option in selected cases where disease is confined and well mapped. On the radiation side, stereotactic radiotherapy delivers precise, higher-dose treatment in a small number of sessions rather than weeks of daily visits, and adaptive radiotherapy systems adjust the plan to the anatomy as it appears on the day of treatment. Bladder and urothelial cancer care has moved similarly, combining endoscopic assessment, intravesical therapy, systemic treatment and reconstructive surgery depending on stage and grade. The common factor is coordination: imaging specialists, pathologists, surgeons, medical oncologists and radiation oncologists reviewing the same case together, which is what a tumor board exists to do. Readers comparing how such care is organized can see how large hospital systems structure their specialty and oncology departments around that team model.
Getting answers rather than opinions
Men in the Gulf and farther afield often start by searching symptoms, which produces a reliable mix of reassurance and alarm in equal measure. A better starting point is a plainly written explanation of what the evidence actually supports — and the health library maintained by Cleveland Clinic Abu Dhabi, whose Cancer Institute runs dedicated programs for testicular, prostate and bladder or urothelial cancer, publishes exactly that kind of material, including a straightforward piece on Prostate cancer facts that separates persistent myths from what screening and treatment involve. The hospital’s genitourinary programs bring together surgical, medical and radiation oncologists with dedicated cancer imaging and pathology specialists, working closely with Cleveland Clinic in the United States, and it also runs an obesity program and resources on weight and sleep — two factors that sit behind a great deal of men’s long-term health risk.
Four things worth doing this month
-
Do one testicular self-exam, and repeat it monthly so you know your own baseline.
-
If you are over 45 — or over 40 with a family history — raise PSA testing at your next appointment and ask for the trade-offs in plain language.
-
Write down the date a symptom started. Clinicians make better decisions with a timeline than with “a while ago”.
-
Treat weight and sleep as medical issues rather than discipline issues; both influence cancer risk and recovery.
None of this is an argument for alarm. It is an argument for information, which is the one thing that reliably shortens the gap between noticing something and having it explained. Nothing in this article replaces an assessment by your own clinician — but a two-minute check and one honest conversation remain the cheapest medicine in men’s health.

